Conference Issue II

The Second Issue of the 4th International Conference and Workshop "Infertility 35+" represents a significant breadth of contemporary reproductive medicine and fertility studies, especially focused on fertility preservation, genetic testing, and the impact of age, disease, and treatment on reproductive health. Many of these papers address crucial concerns in Assisted Reproductive Technology (ART), such as preimplantation genetic testing, ovarian stimulation strategies, and the management of reproductive health in cancer patients.

Key issues include the role of advanced technologies like next-generation sequencing and multi-gene panels in diagnosing hereditary conditions affecting fertility. Additionally, the challenges of managing fertility in older women (35+), recurrent pregnancy loss, and poor prognosis patients are explored through innovative approaches like double vs. single stimulation and personalized ovarian stimulation.

A critical focus on fertility preservation, particularly in cancer patients, underscores the importance of techniques like oocyte cryopreservation and ovarian tissue cryopreservation. The impact of oncological treatments on gonadal function and fertility-sparing in cancers, such as breast and cervical, also plays a vital role in the discussion.

Another major theme is reproductive endocrinology, with studies examining thyroid function, diabetes, and gestational diabetes mellitus about reproductive outcomes. Biochemical pregnancies and the implications of sperm quality with ageing further contribute to the complex landscape of reproductive health.

This body of research emphasizes the multi-disciplinary, global approach to addressing reproductive challenges, particularly in patients facing poor fertility prognosis, genetic disorders, cancer, and the advancing maternal age associated with ART.

MEDICAL TIMES. 4th International Conference and Workshop "Infertility 35+" #2 2023